Back to Journals » Clinical Ophthalmology » Volume 4

Use of nepafenac (Nevanac®) in combination with intravitreal anti-VEGF agents in the treatment of recalcitrant exudative macular degeneration requiring monthly injections

Total article views   HTML views PDF downloads Totals
13,182 Dovepress* 10,918+ 2,044 12,962
PubMed Central* 2,264 375 2,639
Totals 13,182 2,419 15,601
*Since 28 October 2010
+Since July 2016
Total mentioned Facebook Delicious Reddit Twitter Others
1 0 0 0 0 1

View citations on PubMed Central and Google Scholar